Can EBV Cause False-Positive IgM Lyme Disease Results?
Yes, Epstein-Barr virus (EBV) infection can absolutely cause false-positive IgM Lyme disease serology results, and this is a well-documented phenomenon that clinicians must actively consider when interpreting Lyme testing.
The Cross-Reactivity Problem
EBV infection is one of the most common causes of false-positive IgM Lyme serology. The most recent and comprehensive study 1 from 2022 demonstrated that among patients with confirmed active EBV infection:
- 51.9% had positive/borderline IgM results on immunofluorescence testing
- 22.2% had positive/borderline IgM results on ELISA testing
- 11.1% had positive/borderline IgM results on immunoblot (Western blot)
This cross-reactivity occurs because viral infections like EBV trigger polyclonal activation of B lymphocytes, producing antibodies that react with Borrelia antigens—particularly the native flagellin (p41) and OspC proteins 1.
Why This Matters Clinically
The false-positive IgM problem is not trivial. A 2012 study 2 found that 27.5% of patients referred for possible Lyme disease had false-positive IgM immunoblots, and critically, 78% of these patients received unnecessary antibiotic therapy. This represents a significant clinical pitfall.
Earlier research 3 from 1988 and 4 from 1999 both confirmed IgM cross-reactivity specifically with EBV infections, establishing this as a long-recognized diagnostic challenge.
How to Navigate This Diagnostic Dilemma
When you encounter a positive IgM Lyme test in a patient with symptoms that could be either EBV or Lyme disease:
Assess clinical context first: The 2016 CDC guidelines 5 emphasize that patients with erythema migrans in endemic areas can be diagnosed clinically without laboratory testing. Without EM, you need serologic confirmation.
Consider the two-tier testing algorithm: The standard approach uses an initial EIA/ELISA followed by reflex Western blot 5. However, recognize that even with two-tier testing, patients with EBV cannot always be discriminated from those with early Lyme disease 4.
Look for specific clinical features:
- EBV: Pharyngitis, posterior cervical lymphadenopathy, splenomegaly, atypical lymphocytosis
- Lyme: Erythema migrans (70-80% of cases), tick exposure history in endemic area, facial palsy, carditis, or arthritis
Timing matters: A recent case report 6 highlighted that initial Lyme serologies can be negative in early neuroborreliosis, with EBV testing positive instead—only later testing confirmed Lyme disease.
Critical Pitfalls to Avoid
- Don't rely solely on IgM results: False-positive IgM immunoblots are common enough that they should never be the sole basis for diagnosis 2
- Don't assume positive EBV serology excludes Lyme: Case reports 7 document concurrent infections where both are truly present
- Don't over-interpret borderline results: The 2022 study 1 showed that borderline results are particularly problematic with viral infections
The Bottom Line for Clinical Decision-Making
If you have a positive IgM Lyme test in a patient with active EBV infection and no erythema migrans or clear Lyme exposure history, strongly consider this a false-positive result. Treat the EBV clinically and avoid unnecessary antibiotics. If genuine concern for Lyme persists based on epidemiologic exposure and compatible symptoms, consider repeating serologies in 2-4 weeks when convalescent antibodies develop, as sensitivity improves significantly during convalescence 3.
The specificity of two-tier testing exceeds 98% when used correctly 5, but this assumes proper clinical context—viral infections like EBV represent one of the key scenarios where even this high specificity breaks down.